The University of Chicago Header Logo

Connection

Mark Kozloff to Rectal Neoplasms

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Rectal Neoplasms.
Mark Kozloff
Connection Strength
0.190
Rectal Neoplasms
  1. Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer: a phase II study. Future Oncol. 2022 Sep; 18(27):3011-3020.
    View in: PubMed
    Score: 0.190
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.